title: Analysis of risk factors in psoriatic patients with methotrexate-induced increases in transaminase levels.
authors.forename: Vera M R
authors.initials: VM
authors.lastname: Heydendael
authors.forename: Phyllis I
authors.initials: PI
authors.lastname: Spuls
authors.forename: Patrick M M
authors.initials: PM
authors.lastname: Bossuyt
authors.forename: Jan D
authors.initials: JD
authors.lastname: Bos
authors.forename: Menno A
authors.initials: MA
authors.lastname: de Rie
mesh_terms: D000328:Adult; D000367:Age Factors; D000368:Aged; D056486:Chemical and Drug Induced Liver Injury / Q000097:blood / Q000209:etiology*; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D008297:Male; D008727:Methotrexate / Q000009:adverse effects*; D008875:Middle Aged; D011565:Psoriasis / Q000188:drug therapy* / Q000473:pathology; D016032:Randomized Controlled Trials as Topic; D012307:Risk Factors; D012737:Sex Factors; D000637:Transaminases / Q000097:blood
chemical_list: D007166:Immunosuppressive Agents; D000637:Transaminases; D008727:Methotrexate